Allianz Asset Management
VKTX icon

Allianz Asset Management’s Viking Therapeutics VKTX Stock Holding History

Allianz Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$776K Sell
19,883
-2,304
-10% -$74.4K ﹤0.01% 1933
2026
Q1 		$722K Sell
22,187
-47,481
-68% -$1.53M ﹤0.01% 1784
2025
Q4 		$2.45M Sell
69,668
-6,997
-9% -$248K ﹤0.01% 1468
2025
Q3 		$2.01M Buy
76,665
+4,663
+6% +$139K ﹤0.01% 1496
2025
Q2 		$1.91M Sell
72,002
-24,361
-25% -$641K ﹤0.01% 1497
2025
Q1 		$2.33M Sell
96,363
-35,986
-27% -$1.14M ﹤0.01% 1442
2024
Q4 		$5.33M Buy
132,349
+26,306
+25% +$1.5M 0.01% 1010
2024
Q3 		$6.71M Buy
+106,043
New +$6.22M 0.01% 901
2024
Q2 		– Sell
-7,200
Closed -$590K – 2269
2024
Q1 		$590K Buy
+7,200
New +$320K ﹤0.01% 1567
2020
Q2 		– Sell
-87,125
Closed -$408K – 2560
2020
Q1 		$408K Sell
87,125
-1,259
-1% -$7.74K ﹤0.01% 2130
2019
Q4 		$709K Buy
88,384
+847
+1% +$6.17K ﹤0.01% 2318
2019
Q3 		$602K Sell
87,537
-128,533
-59% -$955K ﹤0.01% 2305
2019
Q2 		$1.79M Buy
216,070
+35,271
+20% +$301K ﹤0.01% 1920
2019
Q1 		$1.8M Buy
180,799
+13,006
+8% +$109K ﹤0.01% 1880
2018
Q4 		$1.28M Buy
167,793
+23,361
+16% +$279K ﹤0.01% 1926
2018
Q3 		$2.52M Buy
+144,432
New +$1.72M ﹤0.01% 1858

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management's VKTX Position: Q2 2026 in Review

Allianz Asset Management reduced its Viking Therapeutics (VKTX) stake by 10% in Q2 2026, selling an estimated $74.4K and leaving 19,883 shares worth $776K. The position accounts for ﹤0.01% of the portfolio, ranked #1933.

Allianz Asset Management first reported a position in VKTX in Q3 2018 and has held it in 16 quarters since. The position peaked at $6.71M in Q3 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Allianz Asset Management held 19,883 shares of Viking Therapeutics worth $776K as of Q2 2026.
  • Allianz Asset Management sold 2,304 Viking Therapeutics shares in Q2 2026, an estimated $74.4K.
  • Viking Therapeutics made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1933 holding.
  • Allianz Asset Management first reported a position in Viking Therapeutics in Q3 2018 and has held it in 16 quarters since.
  • Allianz Asset Management's Viking Therapeutics position peaked at $6.71M in Q3 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.